These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30662404)

  • 1. Gallic Acid Potentiates the Antimicrobial Activity of Tulathromycin Against Two Key Bovine Respiratory Disease (BRD) Causing-Pathogens.
    Rajamanickam K; Yang J; Sakharkar MK
    Front Pharmacol; 2018; 9():1486. PubMed ID: 30662404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
    Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
    Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
    Crosby S; Credille B; Giguère S; Berghaus R
    J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Emergence of Resistance to Macrolides and Tetracycline Identified in
    Alhamami T; Chowdhury PR; Gomes N; Carr M; Veltman T; Khazandi M; Mollinger J; Deutscher AT; Turni C; Mahdi L; Venter H; Abraham S; Djordjevic SP; Trott DJ
    Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34204544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A literature review of antimicrobial resistance in Pathogens associated with bovine respiratory disease.
    DeDonder KD; Apley MD
    Anim Health Res Rev; 2015 Dec; 16(2):125-34. PubMed ID: 26373635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tulathromycin metaphylaxis increases nasopharyngeal isolation of multidrug resistant
    Crosby WB; Karisch BB; Hiott LM; Pinnell LJ; Pittman A; Frye JG; Jackson CR; Loy JD; Epperson WB; Blanton J; Capik SF; Morley PS; Woolums AR
    Front Vet Sci; 2023; 10():1256997. PubMed ID: 38053814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between respiratory disease pathogens in calves near feedlot arrival with treatment for bovine respiratory disease and subsequent antimicrobial resistance status.
    Abi Younes JN; Campbell JR; Gow SP; Woolums AR; Waldner CL
    Front Vet Sci; 2024; 11():1416436. PubMed ID: 39109351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
    Coetzee JF; Magstadt DR; Sidhu PK; Follett L; Schuler AM; Krull AC; Cooper VL; Engelken TJ; Kleinhenz MD; O'Connor AM
    PLoS One; 2019; 14(12):e0219104. PubMed ID: 31835273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential oils inhibit the bovine respiratory pathogens Mannheimia haemolytica, Pasteurella multocida and Histophilus somni and have limited effects on commensal bacteria and turbinate cells in vitro.
    Amat S; Baines D; Timsit E; Hallewell J; Alexander TW
    J Appl Microbiol; 2019 Jun; 126(6):1668-1682. PubMed ID: 30817050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota: a Pilot Study.
    Amat S; Timsit E; Workentine M; Schwinghamer T; van der Meer F; Guo Y; Alexander TW
    mSystems; 2023 Apr; 8(2):e0101622. PubMed ID: 36971568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, Risk Factors, and Antimicrobial Resistance Profile of Respiratory Pathogens Isolated From Suckling Beef Calves to Reprocessing at the Feedlot: A Longitudinal Study.
    Nobrega D; Andres-Lasheras S; Zaheer R; McAllister T; Homerosky E; Anholt RM; Dorin C
    Front Vet Sci; 2021; 8():764701. PubMed ID: 34805342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates.
    Clothier KA; Kinyon JM; Griffith RW
    Vet Microbiol; 2012 Apr; 156(1-2):178-82. PubMed ID: 22078276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
    Portis E; Lindeman C; Johansen L; Stoltman G
    J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Metaphylaxis and its Impact on Health, Performance, Antimicrobial Resistance, and Contextual Antimicrobial Use in High-Risk Beef Stocker Calves.
    Credille B; Berghaus RD; Jane Miller E; Credille A; Schrag NFD; Naikare H
    J Anim Sci; 2024 Jan; 102():. PubMed ID: 38126883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Susceptibility of Bacteria That Cause Bovine Respiratory Disease Complex in Alberta, Canada.
    Anholt RM; Klima C; Allan N; Matheson-Bird H; Schatz C; Ajitkumar P; Otto SJ; Peters D; Schmid K; Olson M; McAllister T; Ralston B
    Front Vet Sci; 2017; 4():207. PubMed ID: 29255716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug Resistance in
    Klima CL; Holman DB; Cook SR; Conrad CC; Ralston BJ; Allan N; Anholt RM; Niu YD; Stanford K; Hannon SJ; Booker CW; McAllister TA
    Front Microbiol; 2020; 11():606438. PubMed ID: 33240256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
    Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
    J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of subtherapeutic vs. therapeutic administration of macrolides on antimicrobial resistance in Mannheimia haemolytica and enterococci isolated from beef cattle.
    Zaheer R; Cook SR; Klima CL; Stanford K; Alexander T; Topp E; Read RR; McAllister TA
    Front Microbiol; 2013; 4():133. PubMed ID: 23750157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica.
    Blondeau JM; Borsos S; Blondeau LD; Blondeau BJ; Hesje CE
    Vet Microbiol; 2012 Nov; 160(1-2):85-90. PubMed ID: 22677482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.